David Sterman has worked as an investment analyst for nearly two decades. He started his Wall Street career in equity research at Smith Barney, culminating in a position as Senior Analyst covering European banks. While at Smith Barney, he learned of all the tricks used by Wall Street to steer the best advice to their top clients and their own trading desk.
David has also served as Managing Editor at TheStreet.com and Director of Research at Individual Investor. In addition, David worked as Director of Research for Jesup & Lamont Securities. David has made numerous media appearances over the years, primarily on CNBC and Bloomberg TV, and has a master's degree in management from Georgia Tech.
David Stermanon
Analyst Articles
This market is surely a head-scratcher. Stocks have trended higher for more than three years, even as the United States remains in an economic funk and corporate profits are slowing. The market seems to be ignoring the possibility that if the U.S. Read More
Among the biggest losers in Thursday’s early trading are Pluristem (Nasdaq: PLSTM) and FirstMerit (Nasdaq: FMER). There’s a very good reason why biotech investors are implored to monitor “cash-burn rates.” Many of these companies chew through their funds at a rapid pace, so they need to keep reloading the… Read More
Among the biggest winners in Thursday’s early trading are K12 Inc. (NYSE: LRN) and Equinix (Nasdaq: EQIX). A controversial business model — with robust growth metrics Anyone involved in public education has surely been hearing about K12 Inc. This company has developed… Read More
Investors and traders are an entirely different breed. While investors assess a stock’s value in the context of long-term profit growth, traders solely focus on key near-term events. So while I’ve been convinced that Ford Motor (NYSE: F) represents a compelling long-term investment,… Read More
Among the biggest losers in Wednesday’s early trading are Globecomm Systems (Nasdaq: GCOM) and Xyratex (Nasdaq: XRTX). As the need to quickly access ever-rising streams of corporate data becomes a central mission, a number of companies providing data storage have been able to generate very impressive growth. For example,… Read More
Among the biggest winners in Wednesday’s early trading are Chesapeake Energy (NYSE: CHK) and Facebook (NYSE: FB). Chesapeake’s underwhelming spike By the time it became fully apparent that natural gas giant Chesapeake Energy needed to sell off assets to stave off of a looming liquidity crunch, the damage… Read More
Among the biggest winners in Monday’s early trading are eHealth (Nasdaq: EHTH), Calix (Nasdaq: CALX) and Gafisa (NYSE: GFA). When a company announces a share buyback plan, the stock usually doesn’t budge. That’s because investors often assume that the buyback will simply offset the… Read More
What do Ford (NYSE: F), Bank of America (NYSE: BAC) and Cisco Systems (Nasdaq: CSCO) have in common? They’re all in the clutches of short sellers, and they are all up more than 10% in the past month. It’s no coincidence. Heavily-shorted stocks are some of the… Read More
Among the biggest losers in Tuesday’s early trading are Shuffle Master (Nasdaq: SHFL), Palo Alto Networks (Nasdaq: PANW) and Navidea Biopharma (Nasdaq: NAVB). By the time Zynga (Nasdaq: ZNGA), Groupon (Nasdaq: GRPN) and Facebook (NYSE: FB) all fell out of bed after much-hyped initial public offerings (IPOs), it was… Read More
Among the biggest winners in Monday’s early trading are Peregrine Pharmaceutical (Nasdaq: PPHM) and Century Aluminum (Nasdaq: CENX). The key to find winning investments in biotech: focus on companies that can handily exceed the increasingly stringent restrictions placed on Phase II trials. As noted in today’s look at falling… Read More
